Singer Avery developed osteoporosis after using Ozempic for a year to lose weight. She warns against its misuse, highlighting ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

The Food and Drug Administration's approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1. Today ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

which include Ozempic for diabetes and Wegovy for weight loss. The company said it's exploring the use of semaglutide, a type of GLP-1, for other diseases such as chronic kidney disease ...